Viagra Buys Botox & Why You Should Buy Pfizer
Kent Kwan
AtlasTrend
Pfizer, one of the world’s largest pharmaceutical companies (and the maker of Viagra), has recently announced it is merging with Allergan, best known for being the maker of Botox. Despite being called a merger, the implications of what is effectively Pfizer acquiring Allergan for US$160 billion go well beyond their two most famous products. We think if this transaction proceeds it will create a great outcome for investors. Here are our key reasons why you should consider investing in Pfizer now. Read more at this (VIEW LINK)
Never miss an update
Enjoy this wire? Hit the ‘like’ button to let us know.
Stay up to date with my current content by
following me below and you’ll be notified every time I post a wire
Kent Kwan is a co-founder of AtlasTrend. He was formerly a Chief Investment Officer of an ASX listed company and prior to that was an international equities fund manager with JPMorgan.
2 topics
Kent Kwan
Co-Founder
AtlasTrend
Kent Kwan is a co-founder of AtlasTrend. He was formerly a Chief Investment Officer of an ASX listed company and prior to that was an international equities fund manager with JPMorgan.
Expertise
Kent Kwan
Co-Founder
AtlasTrend
Kent Kwan is a co-founder of AtlasTrend. He was formerly a Chief Investment Officer of an ASX listed company and prior to that was an international equities fund manager with JPMorgan.
Expertise
Comments
Comments
Sign In or Join Free to comment
most popular
Equities
How to choose excellent fund managers
Livewire Markets
Macro
The RBA should warn that it could raise rates again
Coolabah Capital